QDPR
QDPR (quinoid dihydropteridine reductase, also known as DHPR, PKU2 and SDR33C1) is an NADH-dependent enzyme that converts quinonoid dihydrobiopterin into tetrahydrobiopterin. It is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Browse Assay Genie's current range of QDPR research reagents below, or read on for the biology behind the target.
QDPR catalyses the NADH-mediated reduction of quinonoid dihydrobiopterin to give tetrahydrobiopterin. This reaction regenerates the reduced pterin, so the enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Tetrahydrobiopterin is a cofactor for phenylalanine hydroxylase, and the activity of QDPR therefore supports phenylalanine metabolism.
The human QDPR gene encodes a 244-amino-acid protein, dihydropteridine reductase, which belongs to the short-chain dehydrogenase/reductase (SDR) family. The HGNC places it in the short chain dehydrogenase/reductase superfamily, and it is also listed under the aliases DHPR, PKU2 and SDR33C1. Orthologous Qdpr genes are present in mouse and rat, which allows the enzyme to be studied in common rodent models. A subcellular location is not annotated in UniProt.
Mutations in the QDPR gene cause QDPR deficiency. Reported changes include aberrant splicing, amino acid substitutions, insertions and premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria, because insufficient biopterin is produced to serve as a cofactor for phenylalanine hydroxylase. This distinguishes it from classical phenylketonuria and explains the PKU2 alias, and it makes QDPR a useful target for researchers studying pterin metabolism and inherited disorders of phenylalanine handling.
QDPR converts quinonoid dihydrobiopterin into tetrahydrobiopterin, making it a key enzyme for studying how reduced pterin cofactors are regenerated.
Dihydropteridine reductase deficiency presents as atypical phenylketonuria, so QDPR is central to research on biopterin-related disorders of phenylalanine metabolism.
The enzyme is an essential component of pterin-dependent aromatic amino acid hydroxylating systems, supporting work on cofactor supply to hydroxylases.
Splicing defects, amino acid substitutions, insertions and premature terminations in QDPR cause deficiency, providing a basis for genotype-to-function studies.
QDPR, or dihydropteridine reductase, catalyses the NADH-mediated reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin. It is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems, and tetrahydrobiopterin is a cofactor for phenylalanine hydroxylase.
The HGNC-approved name is quinoid dihydropteridine reductase, and UniProt lists the protein as dihydropteridine reductase. Aliases include DHPR, PKU2 and SDR33C1. The last reflects its membership of the short-chain dehydrogenase/reductase family, and PKU2 reflects its link to atypical phenylketonuria.
Mutations in QDPR cause dihydropteridine reductase deficiency, which presents as atypical phenylketonuria due to insufficient biopterin production. Mouse and rat both carry a Qdpr ortholog. Check the datasheet of any product for its validated reactivity.
Other pterin-pathway enzymes and phenylalanine metabolism targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P09417; product specifications from Assay Genie datasheets.